Stocks
Regeneron Financial Statements (REGN) |
||||||||||
| Regeneronsmart-lab.ru | % | 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 08.02.2021 | 07.02.2022 | 31.12.2022 | 06.02.2023 | 05.02.2024 | 31.10.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 8 497 | 16 072 | 12 173 | 12 173 | 13 117 | 13 847 | |||
| Operating Income, bln rub | 3 577 | 8 947 | 4 739 | 4 739 | 4 047 | 4 004 | ||||
| EBITDA, bln rub | ? | 3 901 | 9 281 | 4 918 | 5 335 | 4 654 | 4 831 | |||
| Net profit, bln rub | ? | 3 513 | 8 075 | 4 338 | 4 338 | 3 954 | 4 655 | |||
| OCF, bln rub | ? | 2 618 | 7 081 | 0.000 | 5 015 | 4 594 | 4 247 | |||
| CAPEX, bln rub | ? | 614.6 | 551.9 | 3 763 | 590.1 | 926.4 | 869.8 | |||
| FCF, bln rub | ? | 2 004 | 6 529 | 3 763 | 4 425 | 3 668 | 3 378 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 3 801 | 4 687 | 5 708 | 5 619 | 2 815 | 7 478 | ||||
| Cost of production, bln rub | 1 120 | 2 438 | 800.0 | 1 560 | 1 816 | 2 279 | ||||
| R&D, bln rub | 2 735 | 2 908 | 3 593 | 3 593 | 4 439 | 4 662 | ||||
| Interest expenses, bln rub | 56.9 | 57.3 | 59.4 | 59.4 | 73.0 | 63.0 | ||||
| Assets, bln rub | 17 163 | 25 435 | 29 215 | 29 215 | 33 080 | 37 442 | ||||
| Net Assets, bln rub | ? | 11 025 | 18 769 | 22 664 | 22 664 | 25 973 | 29 326 | |||
| Debt, bln rub | 2 696 | 2 700 | 1 981 | 2 701 | 2 703 | 2 704 | ||||
| Cash, bln rub | 6 723 | 12 533 | 14 334 | 14 334 | 10 845 | 9 797 | ||||
| Net debt, bln rub | -4 027 | -9 833 | -12 353 | -11 633 | -8 142 | -7 093 | ||||
| Ordinary share price, rub | 483.1 | 631.5 | 721.5 | 721.5 | 878.3 | 821.8 | ||||
| Number of ordinary shares, mln | 107.6 | 105.7 | 107.1 | 107.1 | 106.7 | 108.1 | ||||
| Market cap, bln rub | 51 983 | 66 752 | 77 272 | 77 272 | 93 714 | 88 832 | ||||
| EV, bln rub | ? | 47 956 | 56 919 | 64 919 | 65 639 | 85 572 | 81 740 | |||
| Book value, bln rub | 11 025 | 11 917 | 21 749 | 21 749 | 24 935 | 28 206 | ||||
| EPS, rub | ? | 32.7 | 76.4 | 40.5 | 40.5 | 37.1 | 43.1 | |||
| FCF/share, rub | 18.6 | 61.8 | 35.1 | 41.3 | 34.4 | 31.2 | ||||
| BV/share, rub | 102.5 | 112.7 | 203.1 | 203.1 | 233.7 | 260.9 | ||||
| EBITDA margin, % | ? | 45.9% | 57.7% | 40.4% | 43.8% | 35.5% | 34.9% | |||
| Net margin, % | ? | 41.3% | 50.2% | 35.6% | 35.6% | 30.1% | 33.6% | |||
| FCF yield, % | ? | 3.85% | 9.78% | 4.87% | 5.73% | 3.91% | 3.80% | |||
| ROE, % | ? | 31.9% | 43.0% | 19.1% | 19.1% | 15.2% | 15.9% | |||
| ROA, % | ? | 20.5% | 31.7% | 14.9% | 14.9% | 12.0% | 12.4% | |||
| P/E | ? | 14.8 | 8.27 | 17.8 | 17.8 | 23.7 | 19.1 | |||
| P/FCF | 25.9 | 10.2 | 20.5 | 17.5 | 25.6 | 26.3 | ||||
| P/S | ? | 6.12 | 4.15 | 6.35 | 6.35 | 7.14 | 6.42 | |||
| P/BV | ? | 4.71 | 5.60 | 3.55 | 3.55 | 3.76 | 3.15 | |||
| EV/EBITDA | ? | 12.3 | 6.13 | 13.2 | 12.3 | 18.4 | 16.9 | |||
| Debt/EBITDA | -1.03 | -1.06 | -2.51 | -2.18 | -1.75 | -1.47 | ||||
| R&D/CAPEX, % | 445.0% | 526.9% | 95.5% | 608.8% | 479.2% | 536.0% | ||||
| CAPEX/Revenue, % | 7.23% | 3.43% | 30.9% | 4.85% | 7.06% | 6.28% | ||||
| Regeneron shareholders | ||||||||||
